Several life science companies have gotten into the business of developing mobile apps, many of which are directly related to managing diseases their products treat. But the regulatory requirements for designing such apps, especially those that purport to give medical advice, have been fuzzy–until now. This webinar will examine app strategies in the life sciences industry and how they’re changing in the wake of new regulatory requirements.

Webinar Topics Include:

  • Details on the FDA’s guidance on medical smartphone apps and the implications for industry-based app developers
  • Examples of apps developed by pharmaceutical and biotech companies and the regulatory process they endured
  • The growing selection of apps that double as medical devices–interfacing with blood-glucose meters, for example–and their unique regulatory status